Advertisement

Citation tools

Yamaura, Takeshi et al "A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations." Blood (2017): blood-2017-05-786657. Web. 26 May. 2018.